The global single cell analysis market size is expected to
reach USD 5.9 billion by 2025, according to a new report by Grand View
Research, Inc. It is projected to expand at a CAGR of 17.3% during the forecast
period. High demand for early detection techniques and rapid technological
advancements are creating a significant demand for single cell analysis. This
technique is used in genomic, transcriptomic, proteomics, and epigenetic
studies.
Single cell analytics helps assess
cellular heterogeneity and aids in analysis of pathways and processes at a
molecular level. It can be performed with samples as small as a single cell.
Its current applications in diagnostics include genetic analysis, prenatal
screening, cancer genomics, and neurological therapeutics.
Rising prevalence of chronic diseases
is anticipated to drive demand for molecular assay services, subsequently
leading to the growth of this sector. Single cell analysis plays an important
role in risk management related to organ transplants, cancer, heart failure,
renal diseases, and infectious disease testing by performing fast, accurate,
and effective tests.
Browse full research report on Single Cell Analysis Market: https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
Further key findings from the study suggest:
- In 2016, consumables accounted for the largest market share
owing to rapid adoption of beads and microplates, repeat purchase of
reagents, and demand for assay kits
- Automated instruments lead the instruments segment, owing to
their advantages over manually operated variants
- Companies in this market are implementing strategies such as
mergers and acquisitions to expand their product portfolio and to
strengthen their position. The partnership between Illumina, Inc. and
Bio-Rad Laboratories, Inc. is an example of strategies implemented by
leading players
- Major players in this market include, but are not limited to,
Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen N.V.; Bio-Rad
Laboratories, Inc.; Merck Millipore GmbH; Beckman Coulter, Inc. (U.S.);
and Becton, Dickinson and Company (U.S.).
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request/rs1
Grand View Research has segmented the global single cell analysis
market on the basis of product, application, and region:
Single Cell Analysis Product Type Outlook (Revenue, USD Million,
2014 - 2025)
- Consumables
- Reagents
- Assay
Kits
- Other
Consumables
- Instruments
- Manual
Instruments
- Microscopes
- Haemocytometers
- Automated
Instruments
- Flowcytometers
- Next
Generation Sequencing
- PCR
Systems
- High-content
Screening System
- Cell
Microarrays
- Automated
Cell Counters
Single Cell Analysis Application Type Outlook (Revenue, USD
Million, 2014 - 2025)
- Cancer
- Immunology
- Neurology
- Stem
Cell
- Non-invasive
Prenatal Diagnosis
- In-vitro
Fertilization
Single Cell Analysis Regional Outlook (Revenue, USD Million, 2014
- 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- China
- India
- Latin
America
- Mexico
- Brazil
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment